Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation.

Literature DB >> 31253662

Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation.

Ryan Servais¹, Mahmoud A Ammar², Payal K Gurnani³.

Abstract

Blastomycosis-associated acute respiratory distress syndrome (ARDS) has a rare incidence. We report the case of a 29-year-old man with blastomycosis-associated ARDS receiving extracorporeal membrane oxygenation and managed with high-dose liposomal amphotericin B. This case illustrates the importance of timely diagnosis of pulmonary blastomycosis and appropriate dosing of antifungal therapy. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities: Chemical Disease Species

Keywords: infections; pharmacology and therapeutics; pneumonia (infectious disease)

Mesh：

Substances：

Year: 2019 PMID： 31253662 DOI： 10.1136/bcr-2019-229612

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

13 in total

1. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.

Authors: Nilesh M Mehta; David R Halwick; Brenda L Dodson; John E Thompson; John H Arnold
Journal: Intensive Care Med Date: 2007-04-03 Impact factor: 17.440

2. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.

Authors: Stéphanie Ruiz; Emmanuelle Papy; Daniel Da Silva; Patrick Nataf; Laurent Massias; Michel Wolff; Lila Bouadma
Journal: Intensive Care Med Date: 2008-09-16 Impact factor: 17.440

Review 3. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors: Romuald Bellmann; Piotr Smuszkiewicz
Journal: Infection Date: 2017-07-12 Impact factor: 3.553

Review 4. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.

Authors: J Hahn; J H Choi; M J Chang
Journal: J Clin Pharm Ther Date: 2017-09-25 Impact factor: 2.512

Review 5. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.

Authors: Jennifer Sherwin; Travis Heath; Kevin Watt
Journal: Clin Ther Date: 2016-08-21 Impact factor: 3.393

Review 6. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.

Authors: Michael A Ha; Adam C Sieg
Journal: Pharmacotherapy Date: 2017-02-03 Impact factor: 4.705

7. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.

Authors: T J Walsh; J L Goodman; P Pappas; I Bekersky; D N Buell; M Roden; J Barrett; E J Anaissie
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

8. Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.

Authors: M C Allende; J W Lee; P Francis; K Garrett; H Dollenberg; J Berenguer; C A Lyman; P A Pizzo; T J Walsh
Journal: Antimicrob Agents Chemother Date: 1994-03 Impact factor: 5.191